Positron emission tomography in thyroid cancer management
- 1 April 2002
- journal article
- review article
- Published by Elsevier in Seminars in Roentgenology
- Vol. 37 (2) , 169-174
- https://doi.org/10.1016/s0037-198x(02)80035-9
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Radioiodine Ablation of Thyroid Remnants After Preparation with Recombinant Human ThyrotropinThyroid®, 2001
- Current Approaches to Primary Therapy for Papillary and Follicular Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2001
- Preparation by Recombinant Human Thyrotropin or Thyroid Hormone Withdrawal Are Comparable for the Detection of Residual Differentiated Thyroid CarcinomaJournal of Clinical Endocrinology & Metabolism, 2001
- Compassionate Use of Recombinant Human Thyrotropin to Facilitate Radioiodine Therapy: Case Report and Review of LiteratureEndocrine Practice, 2000
- Prognostic Value of [18F]Fluorodeoxyglucose Positron Emission Tomographic Scanning in Patients with Thyroid CancerJournal of Clinical Endocrinology & Metabolism, 2000
- Fluorine-18 fluorodeoxyglucose positron emission tomography in thyroid cancer: results of a multicentre studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin LevelsJournal of Clinical Endocrinology & Metabolism, 1999
- Radiation Dose Assessment for I-131 Therapy of Thyroid Cancer Using I-124 PET ImagingClinical Positron Imaging, 1999
- A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995Cancer, 1998
- Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: implications for diagnosis and therapyJournal of Clinical Endocrinology & Metabolism, 1993